Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment (Q38274981)

1 September 2017

1 reference

title

Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment (English)

1 reference

1 September 2017

1 reference

1 reference

Randy L Luciano

1 reference

1 September 2017

Mark A Perazella

series ordinal

1 reference

1 September 2017

publication date

1 January 2015

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

1 September 2017

page(s)

55-64

1 reference

Traditional chinese medicine: an update on clinical evidence.

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochia: the malignant truth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic acid nephropathy: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic Acid Nephropathy: The Hong Kong Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Activation of p53 promotes renal injury in acute aristolochic acid nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Chinese herbs nephropathy presentation, natural history and fate after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Chinese herbs nephropathy: a clue to Balkan endemic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Urothelial lesions in Chinese-herb nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Splenic large B-cell lymphoma 17 years after exposure to aristolochic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic Acid, an Herbal Carcinogen, Sold on the Web after FDA Alert

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Renal microvascular injury in chronic aristolochic acid nephropathy and protective effects of Cozaar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Critical evaluation of environmental exposure agents suspected in the etiology of Balkan endemic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochic acid and the etiology of endemic (Balkan) nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Aristolochia sp and chronic interstitial nephropathies in Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Etiology of Balkan Endemic Nephropathy and Associated Urothelial Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0244-X

Steroid therapy in chronic interstitial renal fibrosis: the case of Chinese-herb nephropathy

21 January 2018

1 reference

12 December 2020

Urothelial malignancy in nephropathy due to Chinese herbs

1 reference

12 December 2020

Clinical and pathological spectrums of aristolochic acid nephropathy

1 reference

12 December 2020

Etiology of endemic nephropathy

1 reference

12 December 2020

An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy

1 reference

12 December 2020

Chinese herbal uropathy and nephropathy

1 reference

12 December 2020

Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy?

1 reference

12 December 2020

Phytochemical investigations of plants of the genus Aristolochia, 1. Isolation and NMR spectral characterization of eupomatenoid derivatives

1 reference

12 December 2020

Chinese herbs nephropathy and renal pelvic carcinoma

1 reference

12 December 2020

Variation in presentation and presence of DNA adducts and p53 mutations in patients with endemic nephropathy--an environmental form of the aristolochic acid nephropathy

1 reference

12 December 2020

Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model

1 reference

12 December 2020

Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection

1 reference

12 December 2020

Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing

1 reference

12 December 2020

Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy

1 reference

12 December 2020

Nephropathy associated with use of a Chinese herbal product containing aristolochic acid

1 reference

12 December 2020

Genome-wide mutational signatures of aristolochic acid and its application as a screening tool

1 reference

12 December 2020

Chronic renal failure in India

1 reference

12 December 2020

Nephropathy caused by Chinese herbs in the UK

1 reference

12 December 2020

Rapid and specific determination of DNA adducts for clinical diagnosis of poisoning and disease associated with aristolochic acid.

1 reference

12 December 2020

Chinese herb nephropathy

1 reference

12 December 2020

Aristolochic acid nephropathy: variation in presentation and prognosis

1 reference

12 December 2020

Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs

1 reference

12 December 2020

Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy

1 reference

12 December 2020

Tumour induction in mice following exposure to aristolochic acid

1 reference

12 December 2020

Etiology of Balkan endemic nephropathy and associated urothelial cancer

1 reference

12 December 2020

10.1007/S40264-014-0244-X

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1012554879

0 references

1 reference